Zedira specialises in celiac disease. Based on several years of applied research in the Transglutaminase field, Zedira commercialises novel products for research & development and diagnosis of celiac disease. Zedira plans to develop the first drug to treat celiac disease.

Products for Transglutaminase Research:

• Antibodies
• Assays
• Enzymes
• Inhibitors
• Substrates

Products for Celiac Disease Diagnostics:

• Antigens
• ELISA kits